Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, alopecia areata, dermatitis, disorder of pilosebaceous unit, hypotrichosis, skin disorderActive, not recruitingPhase 22026-05-08NCT06018428

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Q32 Bio Inc.2

33 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Austin, TexasAustinUnited States1
Bexley, OhioBexleyUnited States1
Bowling Green, KentuckyBowling GreenUnited States1
Burlington, MassachusettsBurlingtonUnited States1
Clarksville, IndianaClarksvilleUnited States1
Clinical TrialsWinnipegCanada1
Clinical TrialsCantonUnited States1
Clinical TrialsPeterboroughCanada1
Clinical TrialsCalgaryCanada1
Clinical TrialsWaterlooCanada1
Clinical TrialsOakvilleCanada1
Encinitas, CaliforniaEncinitasUnited States1
Fayetteville, ArkansasFayettevilleUnited States2
Fountain Valley, CaliforniaFountain ValleyUnited States1
Frisco, TexasFriscoUnited States1
Hot Springs, ArkansasHot SpringsUnited States1
Houston, TexasHoustonUnited States1
Jordan, UtahJordanUnited States1
Lomita, CaliforniaLomitaUnited States1
Mason, OhioMasonUnited States1
Mayfield Heights, OhioMayfield HeightsUnited States1
Miami, FloridaMiamiUnited States1
New Haven, ConnecticutNew HavenUnited States1
New York, New YorkNew YorkUnited States1
New York, New YorkNew YorkUnited States1